Dengpan Liang

572 total citations
18 papers, 455 citations indexed

About

Dengpan Liang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Dengpan Liang has authored 18 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Dengpan Liang's work include Click Chemistry and Applications (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Dengpan Liang is often cited by papers focused on Click Chemistry and Applications (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Dengpan Liang collaborates with scholars based in China and United States. Dengpan Liang's co-authors include Liangliang Cai, Peijian Wang, Qiulin Wang, Yonghe Hu, Xinzhong Hao, Fang Wang, Bing‐Hu Li, Peng Zhou, Mamoun M. Alhamadsheh and Arindom Pal and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and Carbohydrate Polymers.

In The Last Decade

Dengpan Liang

18 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dengpan Liang China	8	191	138	78	52	50	18	455
Ji‐Hye Song South Korea	16	363 1.9×	120 0.9×	48 0.6×	33 0.6×	14 0.3×	55	658
Zhaoli Meng China	13	244 1.3×	154 1.1×	38 0.5×	32 0.6×	43 0.9×	29	579
Fangshi Zhu China	10	198 1.0×	95 0.7×	100 1.3×	53 1.0×	17 0.3×	25	429
Deokbae Park South Korea	14	274 1.4×	73 0.5×	20 0.3×	47 0.9×	101 2.0×	27	550
Sung Ok Kim South Korea	14	244 1.3×	72 0.5×	36 0.5×	37 0.7×	14 0.3×	27	517
Zhongfei Zhang China	17	339 1.8×	57 0.4×	84 1.1×	45 0.9×	13 0.3×	28	784
Young‐Rak Cho South Korea	14	272 1.4×	62 0.4×	26 0.3×	50 1.0×	16 0.3×	35	512
Celia Vargas‐De‐La‐Cruz Peru	13	183 1.0×	54 0.4×	43 0.6×	36 0.7×	12 0.2×	40	459
Kefeng Zhang China	15	328 1.7×	68 0.5×	33 0.4×	56 1.1×	11 0.2×	52	806

Countries citing papers authored by Dengpan Liang

Since Specialization

Citations

This map shows the geographic impact of Dengpan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dengpan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dengpan Liang more than expected).

Fields of papers citing papers by Dengpan Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dengpan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dengpan Liang. The network helps show where Dengpan Liang may publish in the future.

Co-authorship network of co-authors of Dengpan Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Dengpan Liang. A scholar is included among the top collaborators of Dengpan Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dengpan Liang. Dengpan Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Liang, Dengpan, Amir Kiani, Melanie A. Felmlee, et al.. (2025). Development and preclinical testing of a naloxone prodrug depot for extended protection against opioid overdose. Nature Communications. 16(1). 686–686. 2 indexed citations

Wang, Dan, Yi Yang, Jie Fang, et al.. (2024). Effect of the PCSK9 R46L genetic variant on plasma insulin and glucose levels, risk of diabetes mellitus and cardiovascular disease: A meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 34(6). 1339–1351. 1 indexed citations

Liu, Sen, Jixin Hou, Yi Yang, et al.. (2023). Effect of Intensive Lipid-Lowering Therapy on Coronary Plaque Stabilization Derived from Optical Coherence Tomography: a Meta-analysis and Meta-regression. Cardiovascular Drugs and Therapy. 39(1). 119–132. 6 indexed citations

Liang, Dengpan, et al.. (2022). Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects. Nature Communications. 13(1). 3590–3590. 7 indexed citations

Pal, Arindom, et al.. (2022). Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand. Journal of Medicinal Chemistry. 65(22). 15473–15486. 14 indexed citations

Liang, Dengpan, et al.. (2022). Omentin‑1 induces osteoblast viability and differentiation via the TGF‑β/Smad signaling pathway in osteoporosis. Molecular Medicine Reports. 25(4). 16 indexed citations

Wang, Xinquan, T. Luo, Jixin Hou, et al.. (2022). Adrenal Ablation Versus Mineralocorticoid Receptor Antagonism for the Treatment of Primary Aldosteronism: A Single-Center Prospective Cohort Study. American Journal of Hypertension. 35(12). 1014–1023. 13 indexed citations

Liu, Fang, et al.. (2021). Enhancing the Pharmacokinetic Profile of Interleukin 2 through Site-Specific Conjugation to a Selective Small-Molecule Transthyretin Ligand. Journal of Medicinal Chemistry. 64(19). 14876–14886. 4 indexed citations

Pal, Arindom, Fang Liu, Mark R. Miller, et al.. (2019). Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents. Molecular Pharmaceutics. 16(7). 3237–3252. 19 indexed citations

10.

Cai, Liangliang, et al.. (2018). Structural characterization, antioxidant and hepatoprotective activities of polysaccharides from Sophorae tonkinensis Radix. Carbohydrate Polymers. 184. 354–365. 181 indexed citations

11.

Miller, Mark R., Arindom Pal, Hyun Joo, et al.. (2018). Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis. Journal of Medicinal Chemistry. 61(17). 7862–7876. 66 indexed citations

12.

Wang, Fang, Peng Zhou, Peijian Wang, et al.. (2015). Cinnamaldehyde Prevents Endothelial Dysfunction Induced by High Glucose by Activating Nrf2. Cellular Physiology and Biochemistry. 36(1). 315–324. 107 indexed citations

13.

Wang, Peijian, Qiulin Wang, Yan-Wei Yin, et al.. (2015). Association between Peroxisome Proliferator-activated Receptor Gamma Gene Polymorphisms and Atherosclerotic Diseases: A Meta-analysis of Case-control Studies. Journal of Atherosclerosis and Thrombosis. 22(9). 912–925. 12 indexed citations

14.

Li, Nanfang, Xiaoguang Yao, Hongmei Wang, et al.. (2013). [Association of MK2 gene polymorphisms with low-density lipoprotein cholesterol and tumor necrosis factor-alpha in Uygur population from Hetian area of Xinjiang].. PubMed. 35(1). 52–7. 1 indexed citations

15.

Ma, Xuan, Hongmei Wang, Juan Li, et al.. (2011). Prevalence of metabolic syndrome in patients with primary aldosteronism. Zhonghua neifenmi daixie zazhi. 27(9). 724–728. 1 indexed citations

16.

Liang, Dengpan, et al.. (2011). Epidemiological survey of lipids in individuals of over 30years of age of Kazakan people in Fukang of Xinjiang. International Journal of Cardiology. 152. S40–S40. 1 indexed citations

17.

Wang, Changmin, Nanfang Li, Yanying Guo, et al.. (2011). [Negative association of STAMP2 gene polymorphisms with essential hypertension in Xinjiang Uygur population].. PubMed. 28(1). 64–8. 1 indexed citations

18.

Liang, Dengpan, et al.. (2011). [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].. PubMed. 45(5). 440–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact